Vaccine innovation vs. the bureaucracy

Regulators move the goalposts for a manufacturer that uses mRNA technology.

FDA Letter Stalls Moderna Flu Filing While Stock Trades Above Targets

FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision ...

What the FDA's rejection of Moderna's flu shot means for the future of vaccines

The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.
Scientific American

FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise

America’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots ...
Pulmonology Advisor

COVID-19 Vaccines: Study Compares Humoral Immune Responses of mRNA vs Ad-Vector

In a comparison of COVID-19 vaccines, the mRNA vaccine sustained higher anti-S IgG, while the Ad-vector had superior ...
abc7NY

Moderna COVID vaccine performs as well in children as it does in adults, company says

CHICAGO -- Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday. The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 ...
Nasdaq

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans

CAMBRIDGE, MA / ACCESS Newswire / September 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced positive preliminary immunogenicity data for the 2025-2026 formula of Spikevax®, which targets the LP ...
Yahoo

Covid-19 Vaccine Recommendations | Moderna

Add Yahoo as a preferred source to see more of our stories on Google. Covid-19 infections continue to climb nationwide. And while updated vaccines are available, there is growing confusion over who is ...